{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:44:55Z","timestamp":1789771495560,"version":"4.0.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["15199"],"award-info":[{"award-number":["15199"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["19939"],"award-info":[{"award-number":["19939"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["19784"],"award-info":[{"award-number":["19784"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2010-2310438"],"award-info":[{"award-number":["RF-2010-2310438"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF 2010-2318269"],"award-info":[{"award-number":["RF 2010-2318269"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007366","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"MIUR","doi-asserted-by":"publisher","award":["2010LC747T_004"],"award-info":[{"award-number":["2010LC747T_004"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FIRB","award":["RBAP10TPXK"],"award-info":[{"award-number":["RBAP10TPXK"]}]},{"DOI":"10.13039\/501100004588","name":"Fondazione Cenci Bolognetti","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004588","id-type":"DOI","asserted-by":"publisher"}]},{"name":"International Network Institut Pasteur, Paris"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jaut.2018.10.021","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T09:41:40Z","timestamp":1540546900000},"page":"58-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Viral hepatitis, inflammation, and cancer: A lesson for autoimmunity"],"prefix":"10.1016","volume":"95","author":[{"given":"Silvia","family":"Piconese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Cammarata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Barnaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2018.10.021_bib1","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1707","article-title":"Central tolerance: learning self-control in the thymus","volume":"5","author":"Hogquist","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.immunol.25.022106.141532","volume":"27","author":"Mathis","year":"2009","journal-title":"Aire. Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri701","article-title":"The enemy within: keeping self-reactive T cells at bay in the periphery","volume":"2","author":"Walker","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev-immunol-032712-095948","article-title":"Tissue Tregs","volume":"34","author":"Panduro","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib5","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ni.2691","article-title":"Immune surveillance by the liver","volume":"14","author":"Jenne","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib6","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20162115","article-title":"IL-2(high) tissue-resident T cells in the human liver: sentinels for hepatotropic infection","volume":"214","author":"Pallett","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.10.021_bib7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nm.2002","article-title":"Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters","volume":"15","author":"Feuerer","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2018.10.021_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/279736","article-title":"Appropriate development of the liver Treg compartment is modulated by the microbiota and requires TGF-beta and MyD88","volume":"2014","author":"Maria","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jaut.2018.10.021_bib9","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ni.3799","article-title":"Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues","volume":"18","author":"Delacher","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.28517","article-title":"Human intrahepatic regulatory T cells are functional, require IL-2 from effector cells for survival, and are susceptible to Fas ligand-mediated apoptosis","volume":"64","author":"Chen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.021_bib11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2017.04.023","article-title":"Intrahepatic CD206(+) macrophages contribute to inflammation in advanced viral-related liver disease","volume":"67","author":"Tan-Garcia","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.021_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-3-319-15774-0_2","article-title":"Stability of regulatory T cells undermined or endorsed by different type-1 cytokines","volume":"850","author":"Piconese","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jaut.2018.10.021_bib13","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3389\/fimmu.2017.01889","article-title":"Regulatory T cell metabolism in the hepatic microenvironment","volume":"8","author":"Wawman","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib14","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1159\/000484295","article-title":"Repair' Treg cells in tissue injury","volume":"43","author":"Zhang","year":"2017","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.jaut.2018.10.021_bib15","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI63891","article-title":"Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis","volume":"123","author":"Klingenberg","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.021_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","article-title":"Hepatitis B virus immunopathogenesis","volume":"13","author":"Chisari","year":"1995","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jhep.2010.06.003","article-title":"Hepatitis C virus infection: a \u201cliaison a trois\u201d amongst the virus, the host, and chronic low-level inflammation for human survival","volume":"53","author":"Barnaba","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.021_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nri.2016.69","article-title":"Immune responses and immunopathology in acute and chronic viral hepatitis","volume":"16","author":"Shin","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib19","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.cell.2015.03.005","article-title":"Immunosurveillance of the liver by intravascular effector CD8(+) T cells","volume":"161","author":"Guidotti","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2018.10.021_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","article-title":"Broadly neutralizing antiviral antibodies","volume":"31","author":"Corti","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nri.2016.13","article-title":"Immunological memory: lessons from the past and a look to the future","volume":"16","author":"Farber","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2012.00018","article-title":"The ambiguity in immunology","volume":"3","author":"Barnaba","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib23","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1053\/j.gastro.2018.01.044","article-title":"HBV bypasses the innate immune response and does not protect HCV from antiviral activity of interferon","volume":"154","author":"Mutz","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2018.10.021_bib24","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021428","article-title":"Immune response in hepatitis B virus infection","volume":"5","author":"Tan","year":"2015","journal-title":"Cold Spring Harbor Perspectives Med."},{"key":"10.1016\/j.jaut.2018.10.021_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/ijms.3.47","article-title":"The natural history of hepatitis C virus (HCV) infection","volume":"3","author":"Chen","year":"2006","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.jaut.2018.10.021_bib26","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.3748\/wjg.v20.i24.7653","article-title":"Clinical implications of hepatitis B virus mutations: recent advances","volume":"20","author":"Lazarevic","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jaut.2018.10.021_bib27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib28","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.aaf2807","article-title":"Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade","volume":"354","author":"Pauken","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jaut.2018.10.021_bib29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.immuni.2011.06.015","article-title":"Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells","volume":"35","author":"Youngblood","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2018.10.021_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coi.2015.06.016","article-title":"Host-virus interactions in hepatitis B virus infection","volume":"36","author":"Guidotti","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nri3536","article-title":"T-bet: a bridge between innate and adaptive immunity","volume":"13","author":"Lazarevic","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib32","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/infdis\/jiv460","article-title":"Apoptotic epitope-specific CD8+ T cells and interferon signaling intersect in chronic hepatitis C virus infection","volume":"213","author":"Martini","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jaut.2018.10.021_bib33","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1172\/JCI92812","article-title":"Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation","volume":"128","author":"Rivino","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.021_bib34","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1172\/JCI200420515","article-title":"Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection","volume":"113","author":"Accapezzato","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.021_bib35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nri2189","article-title":"Regulatory T cells and infection: a dangerous necessity","volume":"7","author":"Belkaid","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib36","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/hep.25765","article-title":"Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice","volume":"56","author":"Stross","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.021_bib37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1126\/science.aal1962","article-title":"Mouse models of acute and chronic hepacivirus infection","volume":"357","author":"Billerbeck","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jaut.2018.10.021_bib38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1172\/JCI36604","article-title":"PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV","volume":"119","author":"Franceschini","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.021_bib39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/eji.201243265","article-title":"Induction, control, and plasticity of Treg cells: the immune regulatory network revised?","volume":"43","author":"Barnaba","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2018.10.021_bib41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/eji.201242768","article-title":"HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3\/Gal-9 pathway","volume":"43","author":"Ji","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib42","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1172\/JCI45138","article-title":"Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs","volume":"122","author":"Gupta","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.021_bib43","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.immuni.2018.05.006","article-title":"PD-1 inhibitory receptor downregulates asparaginyl endopeptidase and maintains Foxp3 transcription factor stability in induced regulatory T cells","volume":"49","author":"Stathopoulou","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2018.10.021_bib44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4049\/jimmunol.1200162","article-title":"Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection","volume":"189","author":"Moorman","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib45","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature23665","article-title":"Homeostatic control of metabolic and functional fitness of Treg cells by LKB1 signalling","volume":"548","author":"Yang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2018.10.021_bib46","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1126\/science.aad0616","article-title":"Stable inhibitory activity of regulatory T cells requires the transcription factor Helios","volume":"350","author":"Kim","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jaut.2018.10.021_bib47","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/eji.200838105","article-title":"DNA methylation controls Foxp3 gene expression","volume":"38","author":"Polansky","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib48","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.27188","article-title":"Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus-infected liver tissue","volume":"60","author":"Piconese","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2018.10.021_bib49","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","article-title":"Interferon-gamma drives Treg fragility to promote anti-tumor immunity","volume":"169","author":"Overacre-Delgoffe","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2018.10.021_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006985","article-title":"Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment","volume":"14","author":"Gangaplara","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jaut.2018.10.021_bib51","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1084\/jem.20131556","article-title":"Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection","volume":"211","author":"Srivastava","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.10.021_bib52","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1189\/jlb.5A0415-140R","article-title":"IFN-alpha promotes rapid human Treg contraction and late Th1-like Treg decrease","volume":"100","author":"Pacella","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2018.10.021_bib53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nri2916","article-title":"Phenotypical and functional specialization of FOXP3+ regulatory T cells","volume":"11","author":"Campbell","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib54","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/eji.201243097","article-title":"Upregulation of OX40 ligand on monocytes contributes to early virological control in patients with chronic hepatitis C","volume":"43","author":"Zhang","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib55","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2017.10.021","article-title":"Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40\/OX40L axis","volume":"68","author":"Pollmann","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.021_bib56","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ni.3466","article-title":"Immunometabolism of regulatory T cells","volume":"17","author":"Newton","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib57","doi-asserted-by":"crossref","first-page":"E6546","DOI":"10.1073\/pnas.1720113115","article-title":"Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth","volume":"115","author":"Pacella","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2018.10.021_bib58","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jaut.2018.10.021_bib59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1470-2045(16)30624-6","article-title":"Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study","volume":"18","author":"Hellmann","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jaut.2018.10.021_bib60","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"Postow","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2018.10.021_bib61","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/0952-7915(95)80077-8","article-title":"Manipulation of costimulatory signals to enhance antitumor T-cell responses","volume":"7","author":"Allison","year":"1995","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib62","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1084\/jem.182.2.459","article-title":"CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation","volume":"182","author":"Krummel","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2018.10.021_bib63","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","article-title":"Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death","volume":"11","author":"Ishida","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.jaut.2018.10.021_bib64","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/ni.2762","article-title":"A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application","volume":"14","author":"Okazaki","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib65","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2018.10.021_bib66","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2018.10.021_bib67","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1172\/JCI27745","article-title":"CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells","volume":"116","author":"Quezada","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.021_bib68","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2018.10.021_bib69","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/beta-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2018.10.021_bib70","first-page":"4695","article-title":"Wnt\/beta-catenin signaling in T-cell immunity and cancer immunotherapy","volume":"16","author":"Gattinoni","year":"2010","journal-title":"Clin. Canc. Res. Offic. Jo. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.jaut.2018.10.021_bib71","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1242\/dev.033910","article-title":"Towards an integrated view of Wnt signaling in development","volume":"136","author":"van Amerongen","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.jaut.2018.10.021_bib72","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1158\/2326-6066.CIR-17-0712","article-title":"Wnt3a\/beta-Catenin signaling conditions differentiation of partially exhausted T-effector cells in human cancers","volume":"6","author":"Schinzari","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jaut.2018.10.021_bib73","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","article-title":"T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections","volume":"45","author":"Utzschneider","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2018.10.021_bib74","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1158\/2326-6066.CIR-17-0713","article-title":"Wnt3a neutralization enhances T-cell responses through indirect mechanisms and restrains tumor growth","volume":"6","author":"Pacella","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jaut.2018.10.021_bib75","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1056\/NEJMoa1613512","article-title":"Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection","volume":"376","author":"Bourliere","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2018.10.021_bib76","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.coviro.2016.06.003","article-title":"HBV cure: why, how, when?","volume":"18","author":"Levrero","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jaut.2018.10.021_bib77","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection\u2013natural history and clinical consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2018.10.021_bib78","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1172\/JCI3731","article-title":"Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B","volume":"102","author":"Boni","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.021_bib79","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.01.030","article-title":"TLR7 agonist increases responses of hepatitis B virus-specific T cells and natural killer cells in patients with chronic hepatitis B treated with nucleos(T)ide analogues","volume":"154","author":"Boni","year":"2018","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.jaut.2018.10.021_bib80","doi-asserted-by":"crossref","DOI":"10.1172\/JCI121957","article-title":"PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection","volume":"128","author":"Salimzadeh","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.021_bib81","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1172\/JCI93024","article-title":"Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection","volume":"127","author":"Kah","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.021_bib82","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jhep.2016.05.016","article-title":"Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B","volume":"65","author":"Lok","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2018.10.021_bib83","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1172\/JCI25947","article-title":"Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells","volume":"115","author":"Dannull","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.021_bib84","first-page":"5067","article-title":"Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I\/II study in metastatic melanoma patients","volume":"16","author":"Jacobs","year":"2010","journal-title":"Clin. Canc. Res. Offic. Jo. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.jaut.2018.10.021_bib85","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ccell.2018.02.010","article-title":"Fc effector function contributes to the activity of human anti-CTLA-4 antibodies","volume":"33","author":"Arce Vargas","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jaut.2018.10.021_bib86","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1073\/pnas.1417320112","article-title":"Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients","volume":"112","author":"Romano","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2018.10.021_bib87","first-page":"4327","article-title":"Phase ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, KW-0761, in cancer patients","volume":"21","author":"Kurose","year":"2015","journal-title":"Clin. Canc. Res. Offic. Jo. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.jaut.2018.10.021_bib88","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.immuni.2006.03.001","article-title":"CTLA4Ig: bridging the basic immunology with clinical application","volume":"24","author":"Bluestone","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2018.10.021_bib89","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007542","article-title":"Current and future immunomodulation strategies to restore tolerance in autoimmune diseases","volume":"4","author":"Bluestone","year":"2012","journal-title":"Cold Spring Harbor Perspectives Biol."},{"key":"10.1016\/j.jaut.2018.10.021_bib90","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/imr.12523","article-title":"Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy","volume":"276","author":"Kean","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2018.10.021_bib91","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.4049\/jimmunol.171.7.3348","article-title":"Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells","volume":"171","author":"Tang","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib92","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2018.10.021_bib93","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1172\/JCI78089","article-title":"T cells in the control of organ-specific autoimmunity","volume":"125","author":"Bluestone","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2018.10.021_bib94","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ni.3540","article-title":"An essential role for the IL-2 receptor in Treg cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib95","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri1435","article-title":"Tolerance, not immunity, crucially depends on IL-2","volume":"4","author":"Malek","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib96","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1126\/science.1122927","article-title":"Selective stimulation of T cell subsets with antibody-cytokine immune complexes","volume":"311","author":"Boyman","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jaut.2018.10.021_bib97","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41591-018-0070-2","article-title":"A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism","volume":"24","author":"Trotta","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2018.10.021_bib98","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.4049\/jimmunol.1303417","article-title":"T Cell factor 1 represses CD8+ effector T cell formation and function","volume":"193","author":"Tiemessen","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib99","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4049\/jimmunol.176.3.1439","article-title":"Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo","volume":"176","author":"Willinger","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib100","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm.1982","article-title":"Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells","volume":"15","author":"Gattinoni","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2018.10.021_bib101","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.4049\/jimmunol.1100907","article-title":"Cutting edge: beta-catenin is dispensable for T cell effector differentiation, memory formation, and recall responses","volume":"187","author":"Prlic","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib102","doi-asserted-by":"crossref","first-page":"784","DOI":"10.4049\/jimmunol.1001562","article-title":"Beta-catenin inhibits T cell activation by selective interference with linker for activation of T cells-phospholipase C-gamma1 phosphorylation","volume":"186","author":"Driessens","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib103","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4049\/jimmunol.0901199","article-title":"Constitutive activation of Wnt signaling favors generation of memory CD8 T cells","volume":"184","author":"Zhao","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2018.10.021_bib104","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.immuni.2010.08.002","article-title":"Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1","volume":"33","author":"Zhou","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2018.10.021_bib105","doi-asserted-by":"crossref","first-page":"15050","DOI":"10.1038\/ncomms15050","article-title":"TCF1(+) hepatitis C virus-specific CD8(+) T cells are maintained after cessation of chronic antigen stimulation","volume":"8","author":"Wieland","year":"2017","journal-title":"Nat. Commun."},{"issue":"5993","key":"10.1016\/j.jaut.2018.10.021_bib106","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1126\/science.1188510","article-title":"Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine","volume":"329","author":"Manicassamy","year":"2010","journal-title":"Science"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118306048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118306048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:21:17Z","timestamp":1760257277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841118306048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":106,"alternative-id":["S0896841118306048"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2018.10.021","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral hepatitis, inflammation, and cancer: A lesson for autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2018.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}